14-50247078-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_024884.3(L2HGDH):c.1372C>A(p.Gln458Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000682 in 1,613,328 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_024884.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
L2HGDH | NM_024884.3 | c.1372C>A | p.Gln458Lys | missense_variant | 10/10 | ENST00000267436.9 | NP_079160.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
L2HGDH | ENST00000267436.9 | c.1372C>A | p.Gln458Lys | missense_variant | 10/10 | 1 | NM_024884.3 | ENSP00000267436 | P1 | |
L2HGDH | ENST00000261699.8 | c.1197-9353C>A | intron_variant | 1 | ENSP00000261699 | |||||
L2HGDH | ENST00000421284.7 | c.1372C>A | p.Gln458Lys | missense_variant | 10/11 | 2 | ENSP00000405559 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152116Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251134Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135754
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461212Hom.: 0 Cov.: 32 AF XY: 0.00000688 AC XY: 5AN XY: 726890
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152116Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74300
ClinVar
Submissions by phenotype
L-2-hydroxyglutaric aciduria Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 11, 2019 | This sequence change replaces glutamine with lysine at codon 458 of the L2HGDH protein (p.Gln458Lys). The glutamine residue is weakly conserved and there is a small physicochemical difference between glutamine and lysine. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with L2HGDH-related conditions. This variant is present in population databases (rs754748944, ExAC 0.01%). - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 13, 2023 | The c.1372C>A (p.Q458K) alteration is located in exon 10 (coding exon 10) of the L2HGDH gene. This alteration results from a C to A substitution at nucleotide position 1372, causing the glutamine (Q) at amino acid position 458 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at